by Andrew Mahoney | Jul 16, 2021 | Blog
Interviews with our senior practice managers about issues of important to life science innovators Paul Sagan, Vice President of Investor Relations and Corporate Communications, discusses the growing investment case for ESG reporting within the biotechnology field, the...
by Anna Army | Jan 26, 2021 | Blog
The “2021 Preview: A 360 Degree Global Market View,” virtual webinar was designed to discuss global market trends on public and private United States, Europe, and China markets, JPM virtual week in January 2021, and more. Panelists, including myself as moderator,...
by Anna Army | Jan 26, 2021 | Blog
As we continue with virtual conferences in 2021, here are some tips to help you navigate the digital format and reach your target stakeholders at this year’s virtual conferences. Take advantage of one-on-one partnering systems offered by the conference to get a head...
by Anna Army | Nov 19, 2020 | Blog
LaVoieHealthScience President and CEO, Donna LaVoie, contributed to the O’Dwyer’s PR News Magazine October issue focused on healthcare and medical public relations. Donna discusses what makes strategic communications and investor relations in biotech different from...
by Anna Army | Oct 30, 2020 | Blog
With ESG investing moving from tipping point to turning point, what impact will the new DOL rules have on investors and plan sponsors? Given the macro-level upheavals that have taken place so far in 2020 – from the global pandemic to the movement for racial and...
by Anna Army | Oct 14, 2020 | Blog
As announced last month, the 39th Annual J.P. Morgan Healthcare Conference will be held virtually from January 11-14, 2021 – a first for the conference. The bank’s decision to move to a fully virtual format has created a ripple effect among other shoulder...
Recent Comments